| Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin (NCT05360953) | Charite University, Berlin, Germany | 2022-06-17 |
| A Study of ZG005 in Patients With Advanced Solid Tumors (NCT06233292) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-06-17 |
| Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise (NCT05666128) | Hyundai Pharm | 2022-06-17 |
| Massage for Prostate Cancer-Related Fatigue (mPROSTATE) (NCT05067777) | University of Utah | 2022-06-17 |
| Colchicine in HFpEF (NCT04857931) | Montreal Heart Institute | 2022-06-17 |
| A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants (NCT05412030) | GlaxoSmithKline | 2022-06-16 |
| A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer (NCT05232851) | Mayo Clinic | 2022-06-16 |
| Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer (NCT05364489) | The First Affiliated Hospital of Zhengzhou University | 2022-06-15 |
| A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN (NCT05612633) | Samus Therapeutics, Inc. | 2022-06-15 |
| Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults (NCT05297578) | Vaxcyte, Inc. | 2022-06-15 |
| Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma (NCT05288062) | Mayo Clinic | 2022-06-15 |
| Minnesota HealthSolutions Cellular Car Seat Study (NCT05552027) | Minnesota HealthSolutions | 2022-06-15 |
| Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks (NCT05419505) | Endo USA Inc., a Keenova Therapeutics Company | 2022-06-15 |
| Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690 (NCT05669521) | Tosk, Inc. | 2022-06-15 |
| Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer (NCT04865731) | The University of Texas Health Science Center at San Antonio | 2022-06-15 |
| RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring (NCT05292209) | University of Utah | 2022-06-15 |
| The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma. (NCT05428670) | First Affiliated Hospital of Wenzhou Medical University | 2022-06-15 |
| A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis (NCT05180422) | Criterium, Inc. | 2022-06-15 |
| Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM (NCT06255847) | Shanxi Bethune Hospital | 2022-06-15 |
| Statin Impact on Hepatic Decompensation (NCT05563389) | Tanta University | 2022-06-15 |
| Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation (NCT05378698) | University of Zurich | 2022-06-15 |
| Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. (NCT05369104) | Phagenix | 2022-06-15 |
| Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (NCT05406674) | The Netherlands Cancer Institute | 2022-06-15 |
| NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NCT04452565) | Biomed Industries, Inc. | 2022-06-15 |
| Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients (NCT07610304) | NUR International University | 2022-06-15 |
| A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) (NCT05429320) | Memorial Sloan Kettering Cancer Center | 2022-06-15 |
| Natrunix Versus Methotrexate in Rheumatoid Arthritis (NCT05363917) | XBiotech, Inc. | 2022-06-15 |
| Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas (NCT05105412) | National Health Research Institutes, Taiwan | 2022-06-15 |
| Allopurinol and Quality of Life in Liver Cirrhosis (NCT05828836) | Tanta University | 2022-06-15 |
| Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis (NCT05397938) | Shanghai JMT-Bio Inc. | 2022-06-15 |
| Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC (NCT05386524) | Fudan University | 2022-06-15 |
| A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD) (NCT05258071) | Integrative Research Laboratories AB | 2022-06-15 |
| Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease. (NCT04386590) | Canandaigua VA Medical Center | 2022-06-15 |
| A Study of TG103 Injection in Type 2 Diabetes Subjects (NCT05348122) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2022-06-15 |
| The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) (NCT05238363) | Shanghai Henlius Biotech | 2022-06-15 |
| An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma (NCT05448183) | Xuhua Duan | 2022-06-15 |
| Single or Repeat Dose of G03-52-01 in Adult Subjects (NCT05348993) | U.S. Army Medical Research and Development Command | 2022-06-15 |
| ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05405595) | Adagene Inc | 2022-06-15 |
| Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (NCT05267262) | River 3 Renal Corp. | 2022-06-15 |
| Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients (NCT05632848) | Sun Yat-sen University | 2022-06-15 |
| Allopurinol to Prevent Cirrhosis Related Morbidities (NCT05545670) | Tanta University | 2022-06-15 |
| APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT05186012) | Ascentage Pharma Group Inc. | 2022-06-14 |
| Decreasing Polypharmacy in Older Adults With Curable Cancers Trial (NCT05046171) | University of Rochester | 2022-06-14 |
| RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC (NCT04849377) | Icahn School of Medicine at Mount Sinai | 2022-06-14 |
| A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma (NCT05283720) | Genmab | 2022-06-14 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia (NCT05345938) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-06-14 |
| Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients (NCT05105035) | Arrevus Inc. | 2022-06-14 |
| Post-Operative Pain and Opioid Reduction Trial After Bunionectomy (NCT05411861) | Cali Pharmaceuticals LLC | 2022-06-14 |
| Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (NCT05267821) | Nationwide Children's Hospital | 2022-06-14 |
| Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas (NCT05216120) | HonorHealth Research Institute | 2022-06-14 |
| Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations (NCT05229588) | HonorHealth Research Institute | 2022-06-14 |
| Fedratinib in Combination With Nivolumab (NCT05393674) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-06-14 |
| Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT04850599) | OHSU Knight Cancer Institute | 2022-06-14 |
| Iberdomide Maintenance Therapy in Patients With Multiple Myeloma (NCT05177536) | University of Nebraska | 2022-06-14 |
| Effect of Oral Cimetidine in the Protoporphyrias (NCT05020184) | Amy K. Dickey, M.D. | 2022-06-14 |
| Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain (NCT05470608) | Saol Therapeutics Inc | 2022-06-13 |
| A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma (NCT05420324) | Eucure (Beijing) Biopharma Co., Ltd | 2022-06-13 |
| Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia (NCT05316493) | Xiaojun Chen | 2022-06-13 |
| A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis (NCT05357755) | Janssen Research & Development, LLC | 2022-06-13 |
| E1K Intra Articular(IA) Treatment for Knee Osteoarthritis (NCT05697952) | Ensol Bioscience | 2022-06-13 |
| HAIC Combined With Donafenib and Sintilimab for Unresectable ICC (NCT05348811) | Zhongda Hospital | 2022-06-13 |
| Intravesical LGG VS Saline Bladder Wash RCT (NCT05230511) | Medstar Health Research Institute | 2022-06-13 |
| A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy. (NCT05376904) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2022-06-13 |
| Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC (NCT05265650) | Clinica Universidad de Navarra, Universidad de Navarra | 2022-06-13 |
| Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients (NCT05355766) | Hangzhou Zede Pharma-Tech Co., Ltd. | 2022-06-13 |
| Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP) (NCT05452174) | Northwestern University | 2022-06-13 |
| Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients (NCT05174806) | Microbion Corporation | 2022-06-13 |
| Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer (NCT04952480) | AHS Cancer Control Alberta | 2022-06-13 |
| Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors (NCT05460481) | Hunan Cancer Hospital | 2022-06-12 |
| A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors (NCT05216965) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-06-11 |
| Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer (NCT05403333) | Fudan University | 2022-06-10 |
| Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer (NCT04981509) | National Cancer Institute (NCI) | 2022-06-10 |
| A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis (NCT05364554) | Janssen Research & Development, LLC | 2022-06-10 |
| A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) (NCT04941404) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-10 |
| Probiotics in Systemic Lupus Erythematosus (NCT05433857) | Ain Shams University | 2022-06-10 |
| A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies (NCT05329766) | Arcus Biosciences, Inc. | 2022-06-10 |
| The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder (NCT05312151) | COMPASS Pathways | 2022-06-10 |
| mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC (NCT05412589) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-06-10 |
| Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies (NCT05400889) | Peking University People's Hospital | 2022-06-10 |
| Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis (NCT05119140) | Icahn School of Medicine at Mount Sinai | 2022-06-10 |
| A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain (NCT05419076) | Memorial Sloan Kettering Cancer Center | 2022-06-10 |
| Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib (NCT05280509) | Telios Pharma, Inc. | 2022-06-09 |
| A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) (NCT05384626) | Nuvalent Inc. | 2022-06-09 |
| Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy (NCT05388058) | Mayo Clinic | 2022-06-09 |
| Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia (NCT05393089) | Allergan | 2022-06-09 |
| A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers (NCT05349409) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-06-09 |
| A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (NCT05375760) | AstraZeneca | 2022-06-09 |
| Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer (NCT05429697) | SMT bio Co., Ltd. | 2022-06-09 |
| Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava (NCT05081882) | University of Florida | 2022-06-09 |
| Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts (NCT05415241) | Ruijin Hospital | 2022-06-09 |
| Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma (NCT04894370) | Centre Hospitalier Universitaire de Besancon | 2022-06-09 |
| Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women (NCT05281510) | Gilead Sciences | 2022-06-09 |
| A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (NCT05267600) | argenx | 2022-06-09 |
| BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) (NCT05156710) | Sanofi | 2022-06-09 |
| Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 (NCT05034874) | InterveXion Therapeutics, LLC | 2022-06-09 |
| PARP Inhibition for Gliomas (PI-4G or π4g) (NCT05297864) | University of Oklahoma | 2022-06-09 |
| To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma (NCT05400876) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-09 |
| Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD (NCT05359263) | Tor Biering-Sørensen | 2022-06-08 |
| Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC) (NCT05913427) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2022-06-08 |
| GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites (NCT05438459) | Kyushu University | 2022-06-08 |